B ALL
Clinical trials for B ALL explained in plain language.
Never miss a new study
Get alerted when new B ALL trials appear
Sign up with your email to follow new studies for B ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for older leukemia patients: gentler Two-Drug combo trial launches
Disease control Not yet recruitingThis study is testing whether combining two targeted drugs, inotuzumab and blinatumomab, is a safe and effective first treatment for adults with a type of blood cancer called B-cell acute lymphoblastic leukemia (B-ALL). It is specifically for patients aged 55 and older, or younge…
Matched conditions: B ALL
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Double CAR T-Cell attack aims to stop Leukemia's return
Disease control Not yet recruitingThis study is for children and adults (ages 3-65) with a type of blood cancer called B-cell acute lymphoblastic leukemia (ALL). The goal is to see if giving a second, different CAR T-cell treatment (targeting CD22) to people who are already in remission after their first CAR T-ce…
Matched conditions: B ALL
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC